Tysabri®

What is Tysabri®?

Tysabri® (natalizumab) is a monoclonal antibody used to treat relapsing forms of multiple sclerosis (RMS) in adults. It belongs to a class of therapies called selective adhesion molecule inhibitors, which work by preventing harmful immune cells from crossing into the brain and spinal cord, where they can trigger inflammation and nerve damage.

Tysabri® provides an effective treatment option for individuals with MS, helping to reduce relapse frequency, slow the progression of disability, and prevent the formation of new brain lesions.

How much does Tysabri® cost?

Tysabri® cost can vary depending on insurance provider and coverage. Our team at Rocky Mountain MS Clinic is dedicated to helping make treatment more accessible and affordable for our patients.

We work with most major insurance plans in the Rocky Mountain region, including Aetna, Anthem, Blue Cross Blue Shield, Cigna, Humana, PEHP, and Select Health, along with Medicaid and Medicare.

Our staff manages prior authorizations, benefits verification, and helps patients navigate copay assistance and foundation programs to minimize out-of-pocket expenses.

How does Tysabri® work?

In MS, the immune system mistakenly attacks the myelin sheath — the protective layer around nerves that allows for smooth communication between the brain and body. One of the ways these immune cells reach the brain and spinal cord is by passing through the blood-brain barrier, a layer that normally protects the central nervous system.

Tysabri® helps block this process by targeting molecules called alpha-4 integrins that immune cells use to enter the brain and spinal cord. By stopping these cells from crossing the barrier, Tysabri® reduces inflammation, protects myelin, and supports healthier nerve function.

While not a cure for MS, Tysabri® helps control disease activity, minimize relapses, and protect against long-term neurological damage.

Why Patients Choose Rocky Mountain Infusion Center to Receive Their Tysabri® Infusion:

Clinical Excellence and Neurological Expertise

Our infusion center features board-certified neurologists and a team of BSN-prepared and Multiple Sclerosis-certified Registered Nurses dedicated to providing the highest standard of neurological infusion care.

Lower Costs and Financial Assistance

We handle all insurance coordination and provide direct support with financial aid and copay programs.

A Cigna report recently found that patients receiving care at physician-owned infusion centers, like Rocky Mountain MS Clinic’s, experience lower out-of-pocket and overall costs than those treated in hospital outpatient settings.

Established leader in MS & Neurological care

Over 35 years of serving patients throughout the Intermountain region with expert, compassionate neurological care.

Learn more about Infusion Therapy at RMMSC

Please select the infusion treatment you are interested in.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Positive review from patient at Rocky Mountain Multiple Sclerosis Clinic

The infusion clinic nurses are highly trained in Neurological conditions, personable, professional and careful. Having a doctor and team like this on your side of the fight against MS is invaluable.

Andie L.
Patient
Positive review from patient at Rocky Mountain Multiple Sclerosis Clinic

They are constantly improving their in-house infusion center to ensure the comfort of their patients. The team there is professional and highly trained!

Becky B.
Patient
Positive review from patient at Rocky Mountain Multiple Sclerosis Clinic

As someone who frequents their infusion center on a monthly basis, I can confidently say that it's top-notch. The staff at the infusion center are amazing, providing not only excellent medical care but also creating a comfortable and soothing environment for patients. Their dedication to patient comfort and well-being is evident in every aspect of the center.

Brandon L.
Patient

Important Info

Referral Form:
Tysabri®
What It Treats:

Crohn’s Disease
Multiple Sclerosis

Primary Progressive Multiple Sclerosis

FDA Approval:

Multiple Sclerosis (MS): Approved on November 23, 2004

Crohn’s Disease: Approved on January 14, 2008

Manufacturer:

Biogen